Print full article

Elanco Animal Health becomes stand-alone company

The global animal health company announced its separation from Eli Lilly in 2017

Suggested Veterinary Products

Elanco Animal Health says it is now a fully independent company after completing its split from Eli Lilly.

In 2017, Lilly announced the exploration of potential strategic alternatives for Elanco.

“This is a historic day for everyone at Elanco,” says company president and chief executive officer, Jeff Simmons. “It reflects our team’s hard work over the past two years, and the confidence we have the right strategy and are successfully progressing the execution against it.”

The share exchange was finalized a little less than six months after 19.8 percent of Elanco’s shares were sold to the public. Since then, Elanco reported two quarters of financial and operating results as a standalone company.

“With this milestone behind us, we look forward to a singular focus delivering innovative solutions and services for our customers—the farmers, veterinarians, and pet owners that are central to our success,” Simmons says. “We welcome our new Elanco shareholders who join us and offer our appreciation to our customers, and Lilly for the decades of support.”

Leave a Comment



Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.